Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0378019940370110047
New Medical Journal
1994 Volume.37 No. 11 p.47 ~ p.54
The study on the efficacy, the safety and the tolerance of Zithromax dry syrup in the pediatric infectious diseaseq




Abstract
The efficacy, safety and tolerability were evaluated in pediatric patients treated with Azithromycin dry syrup. Azithromycin dry syrup was administered by 10mg/kg/day for 3 day consecutively in pediatric patients with acute otitis media, pharyngitis, tonsilitis, and pneumoia. 20 patients were valuable at day 3-5 and 10-12 after the start of treatment. At day 3-5 after treatment 85% of patients were clinically cured or improved and 15% were failed. At day 10-12 after treatment 90% of patients were clinically cured or improved and 10% were failed. Adverse events, generally mild, were reported in 10% of the patients whom complained of gastrointestinal events such as diarrhea, vomiting or abdominal pain. No patient discontinued the study because of treatment related side effects. In this study, a 3 day course (10mg/kg/day one dose per day) of Azithromycin dry syrup approved to have acceptable efficacy, safety and tolerability.
KEYWORD
FullTexts / Linksout information
Listed journal information